Skip to main content
. 2022 Apr 26;18(4):e1009962. doi: 10.1371/journal.pcbi.1009962

Table 1. Physicochemical properties and number of assays and cell lines used for validation of anti-cancer capability of studied peptides.

Peptide Name Peptide Length Molecular weight (g/mol) pH(I)* Charge at pH 7 No. of Assays No. of Cell lines Water solubility
FLAK93 5 aa 720.9 10.69 +2 33 117 Good
FLAK50T1 10 aa 1102.41 10.98 +3 16 96 Good
FLAK50T6 11 aa 1230.58 11.15 +4 11 66 Good
FLAK94 7 aa 732.91 9.88 +1 11 65 Poor
C-10 13 aa 1713.16 11.28 +5.1 7 21 Good
Tat 9 aa 1339.61 12.81 +8 6 6 Good
FLAK50 Z1 13 aa 1344.69 11.15 +4 4 24 Good
LfcinB 12 aa 1753.16 11.9 +5.9 4 20 Good
Temporin-La 13 aa 1624.02 10.26 +2.1 2 18 Good
LL-37(17–29) 13 aa 1719.09 11.87 +4 5 13 Good
GA-K4 11 aa 1494.86 11.15 +4 1 9 Good
Cationic Amphiphilic 11 aa 1872.33 11.16 +4 3 6 Good
FLAK-120G 11 aa 1167.53 10.99 +3 2 8 Good
Halictine 1 12 aa 1410.73 11.41 +2.1 2 4 Poor
(HHPHG)2 10 aa 1149.18 7.97 +0.6 3 3 Poor
17 16 aa 1698.19 11.16 +4 1 9 Poor
CAME-15 15 aa 1771.28 11.28 +5 1 10 Good
RGD-La 16 aa 1952.35 10.18 +2.1 1 9 Good
Retro 16 aa 1615.95 9.93 +1 1 9 Poor